Skip to content

News Category: Health & Medical

SoniVie Announces successful procedure with TIVUS system on first patient enrolled for REDUCED1 Pilot study

By asianet

SoniVie, an Israeli company developing a novel proprietary Therapeutic Intra-Vascular Ultrasound (TIVUS(TM)) System to treat a variety of hypertensive disorders, announced that on May 30th 2022 the first patient was treated with its Renal Artery Denervation TIVUS(TM) technology, as part of the recently FDA IDE-approved Pilot study to treat Hypertension (the REDUCED1 study). The procedure … Continued

U.S. Government Secures 3.2 Million Doses of Novavax COVID-19 Vaccine

By asianet

–Agreement will provide the first protein-based vaccine option in the U.S., pending FDA Emergency Use Authorization and CDC recommendation Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced an agreement with the U.S. Department of Health and Human Services (HHS), in collaboration with the … Continued

A new study confirms: EMDR therapy can be done effectively online with remotEMDR

By asianet

A first of its kind academic research confirms that conducting online EMDR therapy using remotEMDR, the world’s leading platform for online EMDR therapy, is safe, effective, efficient, and relevant. Watch remotEMDR’s video to find out more. Eye Movement Desensitization and Reprocessing (EMDR) is an evidence-based psychotherapy that has been recognized by the World Health Organization … Continued

harrison.ai and Sonic Healthcare join forces to launch ‘franklin.ai’, bringing Artificial Intelligence (AI) to pathology

By asianet

franklin.ai aims to apply the latest methodologies in artificial intelligence (AI) to put groundbreaking AI tools into the hands of pathologists. harrison.ai(https://harrison.ai/), the clinically led healthcare AI platform and Sonic Healthcare(https://www.sonichealthcare.com/) (ASX:SHL), the global medical diagnostics leader, have this week officially launched ‘franklin.ai’, a joint venture to advance patient care by integrating digital pathology tools … Continued

Zsquare receives FDA Clearance to Market for First High-Performance Single-Use ENT Endoscope

By asianet

– Company’s patented polymeric fiber is a breakthrough in the world of miniaturizing visualization – Zsquare ENT-Flex(TM) Rhinolaryngoscope advances the ENT category with a best-in-class 2.3mm outer diameter for high-resolution image quality at the lowest cost for the single-use market Zsquare, a leading developer of high-performance, single-use endoscopes, announces that it received Food and Drug … Continued

NHS Scotland awards national laboratory medicine framework to Citadel Health

By asianet

Scotland is on its way to becoming home to the UK’s largest connected laboratory medicine network, following the appointment of Citadel Health ( https://citadelhealth.co.uk/nhs-scotland-awards-national-laboratory-medicine-framework-to-citadel-health/ ) as the supplier for NHS Scotland’s Laboratory Information Management System (LIMS) framework. The new software will connect NHS laboratory medicine labs and hospitals across Scotland. The network has the potential … Continued

EditForce and Mitsubishi Tanabe Pharma Enter into License Agreement

By asianet

EditForce, Inc. (Headquarters: Fukuoka, President and CEO: Takashi Ono; hereinafter “EditForce”) has entered into a License Agreement (hereinafter “Agreement”) with Mitsubishi Tanabe Pharma Corporation (Headquarters: Osaka, Representative Director: Hiroaki Ueno; hereinafter “MTPC”) to research, develop and commercialize potential gene therapy products for a specific target disease in the field of CNS by utilizing EditForce’s proprietary … Continued

Octapharma shares new data at ISTH 2022 in its mission to meet the challenges faced by people with bleeding disorders

By asianet

– Octapharma to present new clinical and scientific data from across Octapharma’s haematology and critical care portfolios during the ISTH 2022 Congress – Data to be presented in 11 poster presentations and during two Supported Symposia – New data from the extensive clinical trial programme with Nuwiq(R) (simoctocog alfa) to be presented, confirming Nuwiq(R)’s efficacy … Continued

Neuromod Publishes Results of Second Large Scale Clinical Trial for Tinnitus in Top-Tier Scientific Journal, Shows Greater Improvement of Symptoms

By asianet

– Second large-scale trial shows greater reduction in tinnitus symptom severity using bimodal neuromodulation device, Lenire(R) – 91% of treatment compliant participants experienced improvement in tinnitus symptoms that sustained 12 months after treatment – 87.8% said they would recommend treatment to others with tinnitus Neuromod Devices Limited, the Irish medical device company specialising in the … Continued